Individualizing duration of antibiotic therapy in community-acquired pneumonia-Reference-Cited by-同舟云学术

Individualizing duration of antibiotic therapy in community-acquired pneumonia

Published:2017-08 Issue: Volume:45 Page:191-201
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Aliberti Stefano,Ramirez Julio,Giuliani Fabio,Wiemken Timothy,Sotgiu Giovanni,Tedeschi Sara,Carugati Manuela,Valenti Vincenzo,Marchioni Marco,Camera Marco,Piro Roberto,Del Forno Manuela,Milani Giuseppe,Faverio Paola,Richeldi Luca,Deotto Martina,Villani Massimiliano,Voza Antonio^ORCID,Tobaldini Eleonora,Bernardi Mauro,Bellone Andrea,Bassetti Matteo,Blasi Francesco^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference13 articles.

1. Community-acquired pneumonia;Wunderink;N. Engl. J. Med.,2014

2. Joint taskforce of the European Respiratory Society and European Society for clinical microbiology and infectious diseases. Guidelines for the management of adult lower respiratory tract infections;Woodhead;Clin. Microbiol. Infect.,2011

3. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia;Ramirez;Arch. Intern Med.,1999

4. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomized trial;Oosterheert;BMJ,2006

5. How to choose the duration of antibiotic therapy in patients with pneumonia;Aliberti;Curr. Opin. Infect. Dis.,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations;Enfermedades infecciosas y microbiologia clinica (English ed.);2024-08

2. ¿Cómo podemos optimizar el abordaje diagnóstico y terapéutico de la neumonía? Recomendaciones basadas en una opinión de expertos;Enfermedades Infecciosas y Microbiología Clínica;2024-07

3. Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial;BMJ Open;2023-07

4. Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis;BMJ Open;2023-03

5. Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study;BMC Geriatrics;2022-12-14